Načítá se...
Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial
INTRODUCTION: Soluble urokinase plasminogen activator receptor (suPAR) is a prognostic and nonspecific biomarker associated with short-term mortality in emergency department (ED) patients. Therefore, the blood level of suPAR might be usable for identification of patients at high- and low risk, short...
Uloženo v:
| Vydáno v: | Scand J Trauma Resusc Emerg Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6458624/ https://ncbi.nlm.nih.gov/pubmed/30975178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13049-019-0621-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|